Myovant Sciences Ltd.
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SUMITOMO CHEMICAL CO., LTD. 10 percent owner
Common Stock 193,900 N/A N/A
Purchase
SUMITOMO CHEMICAL CO., LTD. 10 percent owner
Common Stock 193,900 N/A N/A
Sale
SABLICH KIM officer: Chief Commercial Officer
Common Stock 785 N/A N/A
Purchase
SUMITOMO CHEMICAL CO., LTD. 10 percent owner
Common Stock 193,900 N/A N/A
Purchase
SUMITOMO CHEMICAL CO., LTD. 10 percent owner
Common Stock 193,900 N/A N/A
Purchase
SUMITOMO CHEMICAL CO., LTD. 10 percent owner
Common Stock 193,900 N/A N/A
Sale
SABLICH KIM officer: Chief Commercial Officer
Common Stock 4,840 N/A N/A
Sale
LANG MATTHEW officer: General Counsel & Corp..
Common Stock 19,018 N/A N/A
Sale
KARBE FRANK officer: Principal Fin'l & Acco..
Common Stock 19,701 N/A N/A
Sale
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 45,008,604 N/A N/A
Sale
SABLICH KIM officer: Chief Commercial Officer
Common Stock 2,585 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 75,000 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 170,000 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 75,000 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 179,193 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 3,500,000 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 121,906 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 121,906 N/A N/A
Purchase
SEBELIUS KATHLEEN director
Common Shares 5,000 $8.94 $44,675
Purchase
SEBELIUS KATHLEEN director
Common Shares 5,000 N/A N/A
Purchase
KARBE FRANK officer: Principal Fin'l & Acco..
Common Shares 8,000 N/A N/A
Purchase
DEXXON HOLDINGS LTD. other: See remarks
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, par value $0.000017727 per share 2,424,242 N/A N/A
Purchase
MACHADO PATRICK other: Former 10% Owner
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Purchase
QVT ASSOCIATES GP LLC 10 percent owner
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Purchase
VIKING GLOBAL PERFORMANCE LLC other: Former 10% Owner
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Purchase
SVF INVESTMENTS (UK) LTD other: Former 10% Owner
Common Shares 2,424,242 N/A N/A
Purchase
VIKING GLOBAL INVESTORS LP other: Former 10% Owner
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Purchase
LO ANDREW other: Former 10% Owner
Common Shares, $0.000017727 par value per share 2,424,242 N/A N/A
Sale
ARJONA FERREIRA JUAN CAMILO officer: Chief Medical Officer
Common Stock 260 N/A N/A
Purchase
ROIVANT SCIENCES LTD. 10 percent owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
SVF INVESTMENTS (UK) LTD other: Former 10% Owner
Common Shares 1,110,015 N/A N/A
Purchase
QVT ASSOCIATES GP LLC 10 percent owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
VIKING GLOBAL INVESTORS LP other: Former 10% Owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
LO ANDREW other: Former 10% Owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
VIKING GLOBAL PERFORMANCE LLC other: Former 10% Owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
MACHADO PATRICK other: Former 10% Owner
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Purchase
DEXXON HOLDINGS LTD. other: See remarks
Common Shares, $0.000017727 par value per share 1,110,015 N/A N/A
Sale
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Stock 7,420,625 N/A N/A
Purchase
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Stock 7,420,625 N/A N/A
Purchase
ALTMEYER MARK director
Common Shares 3,500 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Warrant to Purchase Common Shares 4,432 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Shares 4,432 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Warrant to Purchase Common Shares 13,091 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Shares 13,091 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Shares 6,845 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Warrant to Purchase Common Shares 6,845 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Warrant to Purchase Common Shares 5,727 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Common Shares 5,727 N/A N/A
Option
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 10 percent owner
Warrant to Purchase Common Shares 22,141 N/A N/A

Showing 250 to 300 of 303 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.